KALEIDO BIOSCIENCES, INC. Net Income
KALEIDO BIOSCIENCES, INC. reported Net Income of -$90.29 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-01.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2022-04-01
- KALEIDO BIOSCIENCES, INC. net income (loss) attributable to parent for the quarter ending 2021-12-31 was -$20.27M.
- KALEIDO BIOSCIENCES, INC. net income (loss) attributable to parent for the quarter ending 2021-09-30 was -$23.09M.
- KALEIDO BIOSCIENCES, INC. net income (loss) attributable to parent for the quarter ending 2021-06-30 was -$23.89M.
- KALEIDO BIOSCIENCES, INC. net income (loss) attributable to parent for the quarter ending 2021-03-31 was -$23.04M.
- KALEIDO BIOSCIENCES, INC. net income (loss) attributable to parent for fiscal 2021 was -$90.29M.
- KALEIDO BIOSCIENCES, INC. net income (loss) attributable to parent for fiscal 2020 was -$81.62M.
- KALEIDO BIOSCIENCES, INC. net income (loss) attributable to parent for fiscal 2019 was -$86.33M.
- KALEIDO BIOSCIENCES, INC. net income (loss) attributable to parent for fiscal 2018 was -$61.74M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$20.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-01 | -$43.36M derived: sum of 2 quarters · filed 2022-04-01 | -$67.25M derived: sum of 3 quarters · filed 2022-04-01 | -$90.29M 10-K · filed 2022-04-01 |
| 2021-09-30 | -$23.09M 10-Q · filed 2021-11-01 | -$46.97M derived: sum of 2 quarters · filed 2021-11-01 | -$70.02M 10-Q · filed 2021-11-01 | -$90.03M derived: sum of 4 quarters · filed 2022-04-01 |
| 2021-06-30 | -$23.89M 10-Q · filed 2021-11-01 | -$46.93M 10-Q · filed 2021-08-11 | -$66.95M derived: sum of 3 quarters · filed 2022-04-01 | -$90.08M derived: sum of 4 quarters · filed 2022-04-01 |
| 2021-03-31 | -$23.04M 10-Q · filed 2021-11-01 | -$43.06M derived: sum of 2 quarters · filed 2022-04-01 | -$66.19M derived: sum of 3 quarters · filed 2022-04-01 | -$85.11M derived: sum of 4 quarters · filed 2022-04-01 |
| 2020-12-31 | -$20.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-01 | -$43.15M derived: sum of 2 quarters · filed 2022-04-01 | -$62.07M derived: sum of 3 quarters · filed 2022-04-01 | -$81.62M 10-K · filed 2022-04-01 |
| 2020-09-30 | -$23.13M 10-Q · filed 2021-11-01 | -$42.05M derived: sum of 2 quarters · filed 2021-11-01 | -$61.60M 10-Q · filed 2021-11-01 | -$81.12M derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | -$18.92M 10-Q · filed 2021-11-01 | -$38.47M 10-Q · filed 2021-08-11 | -$57.98M derived: sum of 3 quarters · filed 2021-11-01 | -$79.95M derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-03-31 | -$19.55M 10-Q · filed 2021-11-01 | -$39.06M derived: sum of 2 quarters · filed 2021-11-01 | -$61.02M derived: sum of 3 quarters · filed 2021-11-01 | -$85.66M derived: sum of 4 quarters · filed 2021-11-01 |
| 2019-12-31 | -$19.51M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | -$41.47M derived: sum of 2 quarters · filed 2021-03-03 | -$66.11M derived: sum of 3 quarters · filed 2021-03-03 | -$86.33M 10-K · filed 2021-03-03 |
| 2019-09-30 | -$21.96M 10-Q · filed 2020-11-02 | -$46.60M derived: sum of 2 quarters · filed 2020-11-02 | -$66.82M 10-Q · filed 2020-11-02 | -$88.05M derived: sum of 4 quarters · filed 2020-11-02 |
| 2019-06-30 | -$24.64M 10-Q · filed 2020-11-02 | -$44.86M 10-Q · filed 2020-08-04 | -$66.09M derived: sum of 3 quarters · filed 2020-11-02 | -$83.49M derived: sum of 4 quarters · filed 2020-11-02 |
| 2019-03-31 | -$20.22M 10-Q · filed 2020-11-02 | -$41.45M derived: sum of 2 quarters · filed 2020-11-02 | -$58.85M derived: sum of 3 quarters · filed 2020-11-02 | -$71.20M derived: sum of 4 quarters · filed 2020-11-02 |
| 2018-12-31 | -$21.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$38.64M derived: sum of 2 quarters · filed 2020-03-02 | -$50.98M derived: sum of 3 quarters · filed 2020-03-02 | -$61.74M 10-K · filed 2020-03-02 |
| 2018-09-30 | -$17.41M 10-Q · filed 2019-10-30 | -$29.75M derived: sum of 2 quarters · filed 2019-10-30 | -$40.51M 10-Q · filed 2019-10-30 | |
| 2018-06-30 | -$12.35M 10-Q · filed 2019-10-30 | -$23.11M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | -$10.76M 10-Q · filed 2019-10-30 |